Annogen
Biotechnology Research • 
Amsterdam, North Holland, Netherlands • 1-10 Employees
Company overview
| Headquarters | Science Park 406, Amsterdam, 1098 XH, NL |
| Phone number | +31202470020 |
| Website | |
| NAICS | 541714 |
| Keywords | Genomics, Promoters, Gene Expression, Gene Editing, Safe Harbor Loci |
| Founded | 2017 |
| Employees | 1-10 |
| Socials |
Key Contact at Annogen
Joris Van Arensbergen
Founder And Ceo
Annogen Email Formats
Annogen uses 2 email formats. The most common is {first name} (e.g., john@annogen.bio), used 55.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@annogen.bio | 55.6% |
{first initial} | j@annogen.bio | 44.4% |
About Annogen
Bespoke promoters and enhancers, for any tissue, any organism. At Annogen, our vision is a future where safe and effective advanced therapies are specifically expressed in the right tissues with no off-target effects. We believe that this can be achieved by bespoke promoters (genetic switches) and genomic expression sites. Therefore, Annogen is on a mission towards becoming the leading expertise center for gene expression engineering in order to improve the safety and effectiveness of tomorrow's cell and gene therapies. Annogen leverages its proprietary SuRE™ technology to identify regulatory DNA elements to be used for controlled (therapeutic) gene expression for gene & cell therapy, as well as for recombinant protein and virus production. In addition, we develop service projects based on our proprietary AIM™ technology to identify favorable gene insertions and their expression levels for more than 100,000 integrations in parallel. These approaches typically enable big improvements in any biomedical strategy involving the (over-) expression of genes. Annogen was founded in 2017 by Dr. Joris van Arensbergen, who developed and published the SuRE™ technology as a post-doctoral fellow in the laboratory of Prof. Dr. Bas van Steensel at the world-renowned Netherlands Cancer Institute (NKI). Today, Annogen is the trusted partner for bespoke gene expression engineering for leading biopharmaceutical, agricultural and academic research centers globally.
Annogen revenue & valuation
| Annual revenue | $769,995 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,500,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Annogen has 5 employees across 4 departments.
Departments
Number of employees
Funding Data
Annogen has never raised funding before.
Annogen Tech Stack
Discover the technologies and tools that power Annogen's digital infrastructure, from frameworks to analytics platforms.
Maps
JavaScript libraries
CDN
JavaScript libraries
Analytics
JavaScript libraries
Miscellaneous
Security
Programming languages
Blogs
Page builders
Lithuania
United States
Canada
Spain
South Africa
BrazilFrequently asked questions
4.8
40,000 users
